Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI

NCT01158846 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

800

Enrollment

OTHER

Sponsor class

Conditions

ST-Elevation Myocardial Infarction
Primary Percutaneous Coronary Intervention

Interventions

DRUG: prasugrel/bivalirudin
DRUG: clopidogrel/abciximab

Sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Collaborators

[object Object]
[object Object]
[object Object]